Did You Know?

Editor’s Picks

Latest News

Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into new changes in molecular reclassification of hematologic malignancies and their effects in precision...

InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

error: Content is protected !!